We could get a $200k additional fee if we help Cataphora sell
their Legal Ops business (“Success Fee” in the term sheet) –
and I think Jason Kroll may be the guy who could buy it and roll it into his
new company.
------------------------------------------------------------------------------------------
Neil Callahan
Rosemont Seneca
401 Greenwich Street, Suite 400 | New York NY 10013 |
212-933-9965 | 212-796-4037
1010 Wisconsin Avenue, Suite 705 | Washington DC 20007 |
202-333-1880
917-945-9516 (mobile)
866-749-8879 (fax)
From: John DeLoche
[mailto:john@bluebird-capital.com]
Sent: Wednesday, October 06, 2010 5:48 PM
To: Neil; darcher@rosemontseneca.com
Subject: FW: Confidential
FYI attached and below.
Best,
John
------ Forwarded Message
From: John DeLoche <john@bluebird-capital.com>
Date: Wed, 6 Oct 2010 14:46:21 -0700
To: <roysp@cytanet.com.cy>
Subject: Confidential
Roys,
Attached find a proposed term sheet for the bridge financing. For
confidentiality reasons, I cannot send the term sheet we are using with the
lender, but the attached closely mirrors that term sheet with the major change
being the facility has been increased to $2 million verses the $1.2 million
contemplated in our existing discussions. I am happy to discuss offline.
I also attach the company’s historical financials for FY March 2009 and
2010, as well as a forward looking cash flow projection. This forward looking
projection accounts for the potential distraction of the VP of sales of the
legal ops due to the legal ops divestiture process—they should be
considered a downside case. These are the financials off which our current
bridge discussions are taking place.
Please call me with any questions. I am also available to meet tomorrow
afternoon to discuss any of this in more detail.
Best,
John
John DeLoche
Managing Director
Bluebird Capital LLC
415 793 7070 direct
415 373 3878 fax
220 Montgomery Street, #1614
San Francisco, CA 94104
www.bluebird-capital.com
This email communication is privileged and confidential and is intended only
for the individuals or entities named above. Any unauthorized dissemination of
any of the contents of this email is strictly prohibited. If you are not the
intended recipient, please do not read, copy, use or disclose to others the
contents of this communication. Please notify the sender that you have received
this e-mail in error and then delete the e-mail.
------ End of Forwarded Message